| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5537712 | Vaccine | 2016 | 6 Pages |
Abstract
Additionally, PATH, working with BARDA and WHO, supported several DCVMs in the clinical development of influenza vaccine candidates progressing toward national licensure or WHO prequalification. As a result of the activities outlined in this review, several companies were able to make excellent progress in developing state-of-the-art manufacturing processes and completing early phase clinical trials. Licensure trials are currently ongoing or planned for several DCVMs.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Rahnuma Wahid, Renee Holt, Richard Hjorth, Francesco Berlanda Scorza,